Infliximab-induced remission improves physical activity in patients with active Crohn's disease.

Fernando de Azevedo Lucca Carla Malaguti Liliana Andrade Chebli Maycon de Moura Reboredo Bruno do Valle Pinheiro Tarsila Campanha da Rocha Ribeiro Felipe Meirelles de Azevedo José Otávio do Amaral Corrêa Pedro Duarte Gaburri Júlio Maria Fonseca Chebli

Published in: Revista da Associacao Medica Brasileira (1992) (2020)

Infliximab-induced remission was shown to be effective for increasing physical activity by improving the number of steps and reducing inactive time. The maintenance of clinical remission associated with incentives to regular PA may contribute to making these patients reach an ideal level of PA.

Keyphrases

physical activity
ulcerative colitis
high glucose
disease activity
end stage renal disease
diabetic rats
newly diagnosed
ejection fraction
body mass index
chronic kidney disease
drug induced
systemic lupus erythematosus
rheumatoid arthritis
sleep quality
patient reported outcomes
patient reported